Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Pretreatment in ACS PCI
NCT01916902Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Massachusetts General Hospital. Planned start Feb 2014; status: withdrawn.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01916902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916902.